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Logopenic aphasiaThe primary progressive aphasias (PPA) are paradigmatic disorders of language network breakdown
associated with focal degeneration of the left cerebral hemisphere. Here we addressed brain correlates of
PPA in a detailed neuroanatomical analysis of the third canonical syndrome of PPA, logopenic/phonological
aphasia (LPA), in relation to the more widely studied clinico-anatomical syndromes of semantic dementia
(SD) and progressive nonﬂuent aphasia (PNFA). 32 PPA patients (9 SD, 14 PNFA, 9 LPA) and 18 cognitively
normal controls had volumetric brain MRI with regional volumetry, cortical thickness, grey and white matter
voxel-based morphometry analyses. Five of nine patients with LPA had cerebrospinal ﬂuid biomarkers
consistent with Alzheimer (AD) pathology (AD-PPA) and 2/9 patients had progranulin (GRN) mutations
(GRN-PPA). The LPA group had tissue loss in a widespread left hemisphere network. Compared with PNFA
and SD, the LPA group had more extensive involvement of grey matter in posterior temporal and parietal
cortices and long association white matter tracts. Overlapping but distinct networks were involved in the
AD-PPA and GRN-PPA subgroups, with more anterior temporal lobe involvement in GRN-PPA. The
importance of these ﬁndings is threefold: ﬁrstly, the clinico-anatomical entity of LPA has a proﬁle of brain
damage that is complementary to the network-based disorders of SD and PNFA; secondly, the core
phonological processing deﬁcit in LPA is likely to arise from temporo-parietal junction damage but disease
spread occurs through the dorsal language network (and in GRN-PPA, also the ventral language network);
and ﬁnally, GRN mutations provide a speciﬁc molecular substrate for language network dysfunction.
© 2009 Elsevier Inc. Open access under CC BY license. Introduction
Recent research in clinical aphasiology has seen increasing
attention played to the role of distributed networks in language
dysfunction (Hillis, 2007; Rohrer et al., 2008a). The paradigmatic
disorders that illustrate this concept are the primary progressive
aphasias (PPA): a group of neurodegenerative syndromes that affect
predominantly left hemispheric language networks. These disorders
were initially describedwithin the non-Alzheimer dementia spectrum
(Mesulam, 2001, 2003) and have been incorporated into consensus
criteria for frontotemporal lobar degeneration (FTLD) (Neary et al.,
1998). Although two canonical subtypes were originally described—
semantic dementia (SD) and progressive non-ﬂuent aphasia (PNFA)—
more recentworkhas attempted to reﬁne the classiﬁcation of PPAwith
several papers describing a third subtype, known as the logopenic/
phonological variant of PPA (LPA) (Gorno-Tempini et al., 2004, 2008).ing author: J. D. Rohrer. Post-
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license. Whereas the brain correlates of SD and PNFAhave beenwidely studied
less information is available for the LPA subtype. Although initially
reported in early descriptions of PPA (Mesulam, 1982, 2001; Kertesz
et al., 2003), LPA was ﬁrst described in detail by Gorno-Tempini et al.
(2004) and then expanded upon by the same group in a series of
follow-up studies (Rosen et al., 2006; Amici et al., 2006; Gorno-
Tempini et al., 2008; Rabinovici et al., 2008; Brambati et al., 2009;
Wilson et al., 2009). The disorder has been characterized as a primary
phonological loop deﬁcit resulting in impaired verbal short term
(phonological) memory, impaired sentence repetition and compre-
hension with sparse spontaneous speech and frequent prolonged
word-ﬁnding pauses. Anatomically, brain atrophy accompanying LPA
has a perisylvian distribution that overlaps with PNFA, however a left
temporo-parietal correlate has been emphasized in group structural
and metabolic neuroimaging studies (Gorno-Tempini et al., 2008;
Rabinovici et al., 2008;Wilson et al., 2009). Post-mortem and amyloid
imaging studies have emphasized the association of LPA with
Alzheimer's disease (AD) pathology (Mesulam et al., 2008; Rabinovici
et al., 2008). A parallel focus in the dementia literature has been
atypical language variants of AD (Galton et al., 2000; Croot et al., 2000;
Alladi et al., 2007; Stopford et al., 2007, 2008), although reports have
985J.D. Rohrer et al. / NeuroImage 49 (2010) 984–993often been based retrospectively on post-mortem data (Galton et al.,
2000; Croot et al., 2000; Alladi et al., 2007). Thephenotypedescribed in
many of these cases is similar to the LPA syndrome though correlation
is not straightforward as AD pathology has also been associated (albeit
less commonly) with other PPA phenotypes (Knibb et al., 2006;
Gerstner et al., 2007; Rabinovici et al., 2008; Pereira et al., 2009). PPA
may be familial and it has recently been shown that some of these
patients have mutations in the progranulin (GRN) gene (Snowden
et al., 2006;Mesulam et al., 2007). The language phenotype of patients
with GRN mutations has been little studied although they have been
described as nonﬂuent with a prominent anomia (Snowden et al.,
2006, 2007; Rohrer et al., 2008c).
The brain correlates of LPA are of considerable neurobiological as
well as clinical interest. Preliminary studies suggest predominant left
temporo-parietal involvement in this disorder, implying a pattern of
distributed brain damage that is complementary to SD and PNFA
(Gorno-Tempini et al., 2004, 2008;Wilson et al., 2009). This studywas
designed to identify brain imaging features of LPA in relation to SD
and PNFA using complementary imaging techniques of volumetric
measures, cortical thickness analysis and voxel-based morphometry
in a consecutive series of patients presenting with PPA.
Materials and methods
Subject characteristics
Thirty-three consecutive patients fulﬁlling a diagnosis of PPA
according to current criteria (Mesulam, 2001, 2003) and not fulﬁlling
criteria for an alternative dementia syndromewere recruited from theTable 1
Demographic and neuropsychological data.
Mean (standard deviation) SD PNFA
Number of subjects 9 14
%Male 33.3 71.4
Age (years) 62.3 (9.0) 71.8 (6.8
Duration from symptom onset (years) 5.3 (1.2) 5.3 (2.1)
Mini-Mental State Examination (/30) 22.7 (5.2)a 24.4 (5.6
Range of scores 14–28 12–30
CDR score 0.6 (0.2)a 0.6 (0.3)a
Range of scores 0.5–1 0–1
CDR sum of boxes 2.4 (1.5)a 2.4 (1.3)a
Range of scores (0.5–5.5) 0–4.5
Frontal Assessment Battery⁎ (/18) 14.2 (2.2)a 11.4 (3.8
Language
Naming task (/20) 4.4 (3.2)a,b 12.7 (6.4
Single-word repetition task (/30) 29.7 (1.0) 23.4 (9.7
Sentence repetition task (/10) NT1 6.3 (4.1)a
British Picture Vocabulary Scale (/30) 15.1 (5.2)a,b,c 25.4 (4.0
Test for reception of grammar (/20) 16.3 (2.6)a 15.5 (3.1
Irregular word reading task (/30) 15.4 (8.3)a 18.1 (8.6
Graded nonword reading test (/20) NT1 9.6 (6.6)a
Memory
Camden Pictorial Recognition Memory Test (/30) 28.2 (2.2) 29.4(0.8)
Executive function
Trail making test A (scaled score) 8.1 (2.8) 4.1 (2.2)a
Trail making test B (scaled score) 8.0 (3.3) 4.5 (3.3)a
Other cognitive domains
Digit span forwards2 6.8 (1.5) 5.1 (1.4)a
Object decision (VOSP) (/20) 17.2 (2.8) 16.7 (2.3
Graded Difﬁculty Arithmetic Test (/12)3 5.5 (4.2) 3.0 (3.7)a
Limb apraxia (% of cases) 0.0 50.0
Statistically signiﬁcant differences between the SD, PNFA, LPA and control groups are repre
bpb0.05 SD worse than PNFA, cpb0.05 SD worse than LPA, dpb0.05 PNFA worse than SD, ep
only and AD only a superscript lettera represents pb0.05 disease group signiﬁcantly wor
Nonword Reading Test, 25 SD and all of the PNFA, LPA and controls performed this test, 34
⁎ The Frontal Assessment Battery (Dubois et al., 2000) comprises the following subtests:
inhibitory control, and environmental autonomy.tertiary Specialist Cognitive Disorders Clinic of the National Hospital
of Neurology and Neurosurgery, London, UK. All patients had a
structured clinical history, neurological examination and screening
cognitive assessment (Warrington, 2003) performed by an experi-
enced cognitive neurologist (JW, MNR, CM). Based on this initial
assessment and independent of brain imaging ﬁndings, we assigned
patients to three syndromic groups: 9 (27%) were categorized as SD
based on the presence of ﬂuent speech, anomia, impaired word
comprehension and deﬁcits in non-verbal semantic domains (mod-
iﬁed Neary criteria as per Adlam et al., 2006; Neary et al., 1998; Adlam
et al., 2006); 14 (42%) were categorized as PNFA based on the
presence of apraxia of speech and/or agrammatism and relatively
intact single word comprehension (modiﬁed Neary criteria as per
Gorno-Tempini et al., 2004; Neary et al., 1998; Gorno-Tempini et al.,
2004); and 10 patients (30%) were categorized as LPA based on the
presence of word-ﬁnding pauses in spontaneous speech (in the
absence of a motor speech deﬁcit), impaired repetition and compre-
hension of sentences and poor verbal short-term memory (Gorno-
Tempini et al., 2004, 2008). One patient in the LPA group had a cardiac
pacemaker in situ and therefore only 9 patients were included in this
study. A control group of 18 cognitively normal healthy subjects
matched for gender and age was also included. Research ethics
approval for this study was obtained from the National Hospital for
Neurology and Neurosurgery and University College London Hospitals
Research Ethics Committees.
All patients were screened for mutations in theMAPT (exons 1 and
9–13), GRN (all exons) and VCP (exons 3, 5, 6 and 10) genes. Two GRN
mutations were found in patients who had received the diagnosis of
LPA: C31fs, 603_603insC (both previously described in Beck et al.,LPA combined GRN only AD only Controls
9 2 5 18
55.6 50.0 80.0 50.0
) 64.1 (7.4) 60.7 (12.7) 63.1 (4.4) 67.9 (5.4)
4.2 (0.9) 3.7 (0.0) 4.5 (1.0) N/A
)a 15.9 (5.2)a,e,f 16.0 (2.8)a 13.8 (5.7)a 29.7 (0.8)
8–22 14–18 8–22 27–30
0.8 (0.3)a 0.8 (0.4)a 0.7 (0.3)a 0.0 (0.0)
0.5–1 0.5–1 0.5–1 0
4.5 (1.4)a,e,f 4.0 (2.8)a 4.4 (1.3)a 0.0 (0.0)
2–6 2–6 3–5.5 0
)a,d 8.1 (2.0)a,e,f 9.5 (0.7)a 7.4 (1.8)a 17.8 (0.4)
)a 4.0 (4.3)a,f 0.0 (0.0)a 5.6 (4.6)a 19.7 (0.7)
)a,d 22.3 (9.7)a,e 18.5 (2.1)a 26.6 (5.3) 29.8 (0.4)
3.7 (4.0)a,f 0.5 (0.7)a 5.0 (4.3)a 10.0 (0.0)
)a 19.9 (3.5)a,f 15.5 (2.1)a 20.0 (2.3)a 28.3 (0.9)
)a 12.0 (3.5)a,e,f 10.5 (0.7)a 12.6 (4.8)a 19.0 (0.9)
)a 11.4 (6.9)a,f 4.5 (0.7)a 14.4 (6.6)a 28.3 (1.7)
7.7 (6.9)a 6.0 (8.5)a 11.3 (5.5)a 19.7 (0.7)
24.8 (5.1)a,e,f 23.0 (9.9)a 24.2 (4.5)a 29.7 (0.8)
,d 4.7 (3.1)a,e 4.0 (0.0)a 4.5 (3.9)a 9.5 (2.8)
,d 2.5 (1.1)a,e 2.4 (0.2)a 2.2 (0.8)a 9.9 (2.5)
,d 3.7 (1.7)a,e,f 2.5 (0.7)a 3.8 (2.2)a 6.9 (0.6)
) 16.7 (2.4) 19.0 (0.0) 15.6 (2.8) 17.5 (2.3)
1.1 (1.8)a,e 1.5 (2.1)a 0.0 (0.0)a 7.2 (2.1)
100.0 100.0 100.0 0.0
sented by superscript letters: apb0.05 disease group signiﬁcantly worse than controls,
b0.05 LPA worse than SD, fpb0.05 LPA worse than PNFA. For the LPA subgroups of GRN
se than controls. 1SD patients not tested (NT) on sentence repetition task or Graded
SD, 5 PNFA, all of the LPA and 6 controls performed this test.
conceptualization, mental ﬂexibility, motor programming, sensitivity to interference,
986 J.D. Rohrer et al. / NeuroImage 49 (2010) 984–9932008); a thirdmutation (R493X)was found in the LPA patient excluded
from the study. No mutations were found in other genes screened. Of
note, total-tau and Aβ42 cerebrospinal ﬂuid (CSF) biomarker data were
available for six of the seven LPA cases without GRNmutations: all had
raised levels of tau although only ﬁve of the six patients also had low
Aβ42, a CSF proﬁle previously described in association with patholog-
ically proven Alzheimer's disease (Sunderland et al., 2003).
Demographic data, Mini-Mental State Examination (MMSE, Fol-
stein et al., 1975), Frontal Assessment Battery (FAB, Dubois et al.,
2000), Clinical Dementia Rating (CDR, Morris, 1993) in each of the
four groups are presented in Table 1. The general neurological
examination was normal in the majority of patients. However, three
patients in the PNFA group had a parkinsonian syndrome: one had
features of a corticobasal syndrome and two had features of a
progressive supranuclear palsy syndrome. Formal neuropsychological
assessment was performed in all of the subjects (Table 1, details of
tests available in supplementary information) with characteristic
neuropsychological proﬁles exhibited by both the SD group (anomia,
single word comprehension, intact repetition and surface dyslexia)
and the PNFA group (impaired sentence comprehension, poor single
word and sentence repetition with apraxic errors, mild anomia and
phonological dyslexia). In comparison, patients with LPA exhibited
more severe verbal short term memory deﬁcits (digit span forwards),
sentence comprehension and sentence repetition deﬁcits than the
other groups, similar to previous descriptions (Gorno-Tempini et al.,
2004, 2008). On a single-word comprehension (word–picture
matching) task, patients with LPA performed worse than the PNFA
group but better than the SD group. Other features in the LPA group
included deep/phonological dyslexia (difﬁculty reading non-words,
but with a mixture of error types, including semantic and visual
errors: Coltheart, 1980; Crisp and Lambon Ralph, 2006; Brambati et
al., 2009) and other left parietal lobe deﬁcits (impaired limb praxis,
dyscalculia), also consistent with previous reports of LPA (Amici et al.,
2006; Gorno-Tempini et al., 2008).
Patients receiving a diagnosis of LPA with GRN mutations (GRN-
PPA) were compared clinically and neuropsychologically with LPA
patients who had CSF biomarkers consistent with AD (AD-PPA):Table 2
(A) Volumetric data for whole brain, left and right cerebral hemisphere, caudate, hippocamp
thickness data for the frontal, temporal and parietal lobes.
A
Cerebral region volumes (as a percentage of TIV),
mean (standard deviation)
SD PNFA
Whole brain 68.1 (3.8) 64.2 (5.7
Left hemisphere 32.7 (2.0) 31.1 (2.9
Right hemisphere 34.7 (1.8) 32.2 (2.8
Left/right hemispheric ratio 0.94 (0.01)a,b 0.97 (0.0
Brainstem 1.26 (0.11) 1.20 (0.1
Left caudate 0.20 (0.03) 0.19 (0.0
Right caudate 0.22 (0.03) 0.20 (0.0
Left hippocampus 0.13 (0.04)a,b,c 0.20 (0.0
Right hippocampus 0.21 (0.03) 0.22 (0.0
Left amygdala 0.04 (0.02)a,b,c 0.08 (0.0
Right amygdala 0.07 (0.02)a,b,c 0.08 (0.0
B
Cortical thickness in each lobe (mm),
mean (standard deviation)
Frontal Left 2.2 (0.1) 2.0 (0.2
Right 2.3 (0.1) 2.1 (0.1
Temporal Left 1.7 (0.2) a,b 2.1 (0.3
Right 2.2 (0.2)a 2.2 (0.2
Parietal Left 2.0 (0.1) 1.8 (0.2
Right 2.1 (0.1) 1.9 (0.2
Statistically signiﬁcant differences between the SD, PNFA, LPA and control groups are repre
bpb0.05 SD worse than PNFA, cpb0.05 SD worse than LPA, dpb0.05 PNFA worse than SD, ep
only and AD only a superscript lettera represents pb0.05 disease group signiﬁcantly worsesubgroup data are summarized in Table 1. The AD-PPA group
undoubtedly ﬁt the proposed criteria for LPA with impoverished
spontaneous speech, a phonological store deﬁcit (decreased forwards
digit span) and impairment of both sentence repetition and
comprehension (Gorno-Tempini et al., 2008). In comparison the
GRN-PPA group exhibit similar features but with signiﬁcantly worse
(p=0.02) performance on reading irregular words and a trend to
more severe impairments of naming, single word comprehension and
repetition.
Brain image acquisition and analyses
MR brain images were acquired on a 1.5-T GE Signa scanner
(General Electric, Milwaukee, WI) using an IR-prepared fast SPGR
sequence (TE=5 ms, TR=12 ms, TI=650 ms). T1-weighted volu-
metric images were obtained with a 24-cm ﬁeld of view and 256×256
matrix to provide 124 contiguous 1.5-mm-thick slices in the coronal
plane.
Volumetric imaging
Image analysis was performed using the MIDAS software package
(Freeborough et al., 1997). Scans were outlined using a rapid semi-
automated technique which involves interactive selection of thresh-
olds, followed by a series of erosions and dilations. This yields a region
which separates brain from surrounding CSF, skull and dura. Scans
and associated brain regions were subsequently transformed into
standard space by registration to the Montreal Neurological Institute
(MNI) Template (Mazziotta et al., 1995). The left and right
hemispheric regions were deﬁned using the MNI average brain
which was split by dividing the whole volume along a line coincident
with the interhemispheric ﬁssure. An intersection of each individual's
brain region and the hemispheric regions deﬁned on the MNI
template was generated to provide a measure of brain volume in
left and right hemispheres (Chan et al., 2001; Beck et al., 2008). Left/
right volume ratios were subsequently calculated. Volumetric analysis
of speciﬁc subcortical structures (hippocampus, amygdala, caudate
and brainstem) was performed using the Freesurfer imageus and amygdala volumes as a percentage of total intracranial volume (TIV), (B) cortical
LPA GRN only AD only Controls
)a,d 65.1 (5.6)a 63.2 (0.8) 66.3 (6.3) 70.1 (4.0)
)a 30.7 (3.0)a 28.3 (0.2)a 31.8 (2.9)a 34.4 (1.9)
)a,d 33.6 (2.8) 33.9 (0.3) 33.7 (3.4) 34.6 (2.0)
4)a 0.91 (0.05)a,f 0.83 (0.00)a 0.94 (0.01)a 1.00 (0.01)
5) 1.22 (0.12) 1.21 (0.07) 1.23 (0.14) 1.27 (0.10)
3)a 0.19 (0.02)a 0.19 (0.01) 0.18 (0.01)a 0.22 (0.03)
2)a 0.22 (0.03) 0.24 (0.01) 0.20 (0.02) 0.23 (0.04)
3) 0.18 (0.05)a 0.15 (0.02)a 0.19 (0.04)a 0.22 (0.03)
3) 0.22 (0.04) 0.21 (0.00) 0.22 (0.04) 0.24 (0.03)
1) 0.07 (0.02)a 0.07 (0.02) 0.07 (0.02)a 0.08 (0.01)
1) 0.09 (0.02) 0.11 (0.00) 0.09 (0.02) 0.09 (0.01)
)a,d 1.9 (0.1)a,e 1.9 (0.1)a 1.9 (0.1)a 2.2 (0.1)
)a,d 2.1 (0.1)e 2.3 (0.0) 2.1 (0.1)a 2.2 (0.1)
)a 1.8 (0.1)a,f 1.6 (0.4)a 1.9 (0.1)a 2.4 (0.1)
)a 2.3 (0.1) 2.5 (0.1) 2.2 (0.1)a 2.4 (0.1)
)a,d 1.7 (0.1)a,e 1.8 (0.1)a 1.7 (0.1)a 2.0 (0.1)
)a,d 2.0 (0.1)e 2.2 (0.1) 1.8 (0.1)a 2.0 (0.1)
sented by superscript letters: apb0.05 disease group signiﬁcantly worse than controls,
b0.05 LPA worse than SD, fpb0.05 LPA worse than PNFA. For the LPA subgroups of GRN
than controls.
987J.D. Rohrer et al. / NeuroImage 49 (2010) 984–993analysis suite version 4.0.3 (http://surfer.nmr.mgh.harvard.edu/)
(Fischl et al., 2002), on a 64-bit Linux CentOS 4 Sun Grid Engine
Cluster. Initially, the four groups (SD, PNFA, LPA and controls) were
compared statistically by looking at the two-tailed contrasts between
the group means using a linear regression model (STATA8©, Stata
Corp, College Station, TX). Subgroup analyses with SD, PNFA, GRN-PPA
only, AD-PPA only and controls were also performed.
Cortical thickness analysis
Cortical reconstruction and thickness estimation was performed
with the Freesurfer image analysis suite (Dale et al., 1999; Fischl et al.,
2000): more detailed methods are available in supplementary online
information. To reduce the standard deviation of the thickness
measurement across the cohort, we applied a small surface-based
Gaussian smoothing of 20 mm full width at half-maximum (selected
based on likely effect size) (Dale et al., 1999). A vertex-by-vertex
linear regression analysis was performed using the SurfStat software
(http://www.stat.uchicago.edu/∼worsley/surfstat/) to examine dif-
ferences in cortical thickness between the patient groups and the
control group. Cortical thickness, C, was modeled as a function of
group, controlling for age, gender and total intracranial volume
by including them as nuisance covariates. C=β1 SD + β2 PNFA + β3
LPA+ β4 controls + β5 age + β6 gender + β7 TIV + μ+ ɛ (where μ is
a constant, and ɛ is error). In separate analyses, we compared
subgroups with AD-PPA (the ﬁve patients with CSF biomarker data
consistent with Alzheimer pathology) and GRN-PPA (the two patients
with GRN mutations) with each other and with SD, PNFA, and
controls. Contrasts of interest between the estimates of the groupFig. 1. Cortical thicknessmaps showing patterns of cortical thinning in disease groups compared
right hemisphere sections below.Maps are thresholded at pb0.001 after FDR correction over th
group, the composite map “AD/GRN overlap” codes areas inwhich cortical thinning was observ
(orange) relative to healthy controls at the prescribed threshold.parameters were assessed using two-tailed t-tests. Maps showing
statistically signiﬁcant differences between each disease group and
healthy controls were generated and corrected for multiple compar-
isons to control the False Discovery Rate (FDR) at a 0.001 signiﬁcance
level. For disease group comparisons maps were thresholded at an
FDR corrected 0.05 signiﬁcance level.
Voxel-based morphometry analysis
Voxel-based morphometry (VBM) was performed using SPM5
software (http://www.ﬁl.ion.ucl.ac.uk/spm) and the DARTEL toolbox
with default settings for all parameters: more detailed methods are
available in supplementary online information. Linear regression
models were used to examine differences in GM and WM volume
between the groups. Voxel intensity, V, was modeled as a function of
group, and subject age gender and total intracranial volume were
included as nuisance covariates. V=β1 SD + β2 PNFA + β3 LPA + β4
controls + β5 age+ β6 gender + β7 TIV + μ + ɛ (where μ is a
constant, and ɛ is error). Similar analyses were performed separately
for the AD-PPA and GRN-PPA subgroups. The analysis was performed
over voxels inside a “consensus mask” (Ridgway et al., 2009), which
included all voxels where intensityN0.1was present inN70% of subjects.
Separate analyses were performed on the grey and white matter
segments.Maps showing single-tailed statistically signiﬁcantdifferences
between the groups were generated, correcting for multiple compar-
isons in the disease group-control comparisons by thresholding the
images of t-statistics to control the False Discovery Rate (FDR) at a 0.05
signiﬁcance level. For disease group comparisons maps were generated
uncorrected at a 0.001 signiﬁcance level. Statistical parametric mapsto healthy controls. For each disease panel, left hemisphere sections are shown above and
ewhole brain volume. The colored bar represents FDR corrected p-values. Within the LPA
ed only in the AD-PPA group (green), only in the GRN-PPA group (blue) or in both groups
988 J.D. Rohrer et al. / NeuroImage 49 (2010) 984–993were displayed as overlays on a study-speciﬁc template, created by
warping all native space whole-brain images to the ﬁnal DARTEL
template and calculating the average of the warped brain images.
Results
Volumetric analysis
All PPA groups had asymmetrical predominantly left-sided
cerebral atrophy (Table 2). However, hemispheric asymmetry was
more marked in the SD and combined LPA groups. The subgroup
analysis revealed markedly asymmetric atrophy in the GRN-PPA
subgroup (L/R ratio=0.83) which was signiﬁcantly more asymmetric
than all other disease groups; atrophy in the AD-PPA subgroup was
similar to the SD group in terms of asymmetry (L/R ratio=0.94) and
signiﬁcantly more asymmetric than the PNFA group.
Subcortical volumetric data showed smaller caudate volumes
bilaterally in the PNFA group compared to controls (with a trend to
smaller brainstem volume also) and smaller left hippocampal and
bilateral amygdala volumes in the SD group compared to controls. In
the combined LPA group, the left caudate, hippocampus and amygdala
were signiﬁcantly smaller than controls and these ﬁndings were
similar in the AD-PPA subgroup, while the left hippocampus was
signiﬁcantly smaller only in the GRN-PPA subgroup.
Cortical thickness analysis
Compared with healthy controls, cortical thinning was predomi-
nantly left-sided in all three PPA groups (Fig. 1, Table 2B). The SDFig. 2. Cortical thickness maps showing patterns of cortical thinning in between disease-grou
right hemisphere sections on the right. Maps are thresholded at pb0.05 after FDR correctiogroup showed involvement of the antero-inferior temporal lobes (left
greater than right and particularly the temporal pole, parahippocam-
pal and entorhinal cortex) and to a lesser extent the left frontal lobe
(particularly orbitofrontal cortex) (Fig. 1) while in the PNFA group
there was maximal involvement of the left inferior frontal (pars
triangularis and pars opercularis), superior frontal, insular and
superior temporal cortex with lesser involvement of the anterior
parietal lobe (Fig. 1). In the combined LPA group there was more
widespread involvement of the left hemisphere with the areas of most
signiﬁcant cortical thinning in the posterior temporal lobe (particu-
larly superior and middle temporal gyri), medial temporal lobe,
inferior parietal lobe and frontal lobe (inferior, middle and orbito-
frontal gyri) with lesser involvement of the precuneus (Fig. 1). The
subgroup analysis of GRN-PPA and AD-PPA revealed overlapping but
distinct patterns in the two subgroups compared to controls
(Fig. 1): both groups had mid to posterior temporal lobe and
inferior frontal involvement but in the AD-PPA group there was
greater temporo-parietal junction and frontal atrophy and in the
GRN-PPA group there was more anterior temporal atrophy (Fig.
1). Comparing patterns of maximal cortical thinning between the
AD-PPA and GRN-PPA subgroups and the other disease groups,
there was greater posterior temporal, inferior parietal and inferior
frontal lobe involvement in the AD-PPA subgroup than the SD group
(with more anterior temporal lobe involvement in SD), but no
signiﬁcant differences with respect to the PNFA group; while in the
GRN-PPA subgroup there was greater left inferior frontal lobe
involvement than the SD group (with more right anterior temporal
lobe thinning in SD), and more anterior temporal lobe involvement
compared to the PNFA group (with more right hemispherep differences. For each disease panel, left hemisphere sections are shown on the left and
n over the whole brain volume. The colored bar represents FDR corrected p-values.
Fig. 3. VBM analysis on greymatter regions in PPA groups relative to healthy controls. For each axial section, the left hemisphere is shown on the left; sagittal sections are through the
left hemisphere. Maps are thresholded at pb0.05 after FDR correction over the whole brain volume. Grey matter differences are color coded (red-yellow) in terms of t-score as
indicated on the color bar (right).
989J.D. Rohrer et al. / NeuroImage 49 (2010) 984–993involvement in PNFA) (Fig. 2). On direct comparison of the LPA
subgroups, the AD-PPA subgroup had more marked thinning of left
anterior parietal cortex and extensive cortical areas in the right
cerebral hemisphere, while the GRN-PPA subgroup had more
marked thinning of left anterior temporal cortex (Fig. 2).
VBM analysis
The VBM analysis corroborated the ﬁndings of the cortical
thickness analysis with similar ﬁndings in the SD and PNFA groups
compared to controls and in the LPA group, maximal involvement of
the left posterior temporal, inferior parietal and inferior frontal lobes
compared to controls (Fig. 3). In the subgroup analyses in relation to
healthy controls, patterns of grey matter atrophy overlapped in the
AD-PPA and GRN-PPA subgroups, but the AD-PPA subgroup had
greater posterior (particularly parietal) involvement while the GRN-
PPA subgroup had greater anterior temporal lobe involvement
(Fig. 3). The ﬁndings differed from the cortical thickness measures
in showing greater overlap between the AD-PPA and GRN-PPA
subgroups in posterior temporal, inferior parietal and inferior frontal
lobe areas. Comparing patterns of most signiﬁcant grey matter loss in
the LPA subgroups, the AD-PPA subgroup had greater left posterior
temporal, parietal and inferior frontal atrophy than the SD group, and
greater left inferior temporal involvement than the PNFA group; while
the GRN-PPA subgroup had greater inferior frontal and precuneus
involvement than the SD group, and greater temporal lobe involve-
ment than the PNFA group (Fig. 4). On direct comparison of the LPA
subgroups, the AD-PPA subgroup had greater atrophy in biparietal
and right posterior temporal cortices, while the GRN-PPA subgroup
had greater atrophy of left anterior and inferior temporal and left
orbitofrontal cortex (Fig. 4).The white matter analysis revealed distinct patterns of tract
involvement in each of the three groups: in the SD group, there was
involvement of whitematter tracts predominantly in the left temporal
lobe including the fornix, inferior longitudinal fasciculus and uncinate
fasciculus (Fig. 5); in the PNFA group, there wasmaximal involvement
of a left frontal lobe white matter region likely to represent part of the
superior longitudinal fasciculus (Fig. 5); and in the LPA group there
wasmorewidespreadwhitematter involvement predominantly in the
left hemisphere, including the intrahemispheric long association tracts
(inferior longitudinal fasciculus, superior longitudinal fasciculus,
inferior fronto-occipital fasciculus and cingulum) as well as the fornix
(Fig. 5). Comparing patterns of maximal white matter loss between
disease groups relative to healthy controls (Fig. 5), the GRN-PPA
subgroup had most marked involvement of intrahemispheric long
association tracts including inferior longitudinal fasciculus, superior
longitudinal fasciculus, inferior fronto-occipital fasciculus and cingu-
lum, and also involvement of the corpus callosumandbrainstem tracts.
The GRN-PPA subgroup showed greater involvement of dorsal fronto-
parietal tracts than the SD group, greater involvement of temporal lobe
tracts than the PNFA group, and greater involvement of both fronto-
parietal and temporal lobe tracts than the AD-PPA subgroup. The AD-
PPA subgroup had no signiﬁcant white matter involvement relative to
either healthy controls or the disease subgroups.
Discussion
Here we present a detailed neuroanatomical characterization of
LPA in comparison to the canonical PPA subtypes, SD and PNFA; and in
particular, neuroanatomical signatures of LPA subgroups with GRN
mutations and with probable AD pathology. Allowing for the different
modalities used and the limited spatial resolution of smoothed data
Fig. 4. VBM analysis on grey matter regions in disease group comparisons. For each axial section, the left hemisphere is shown on the left. Maps are thresholded at pb0.001
uncorrected. Grey matter differences are color coded (red-yellow) in terms of t-score as indicated on the color bar (lower right).
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cortical thickness and morphometric techniques here have shown a
broadly convergent pattern of ﬁndings. The LPA syndrome is
associated with asymmetrical atrophy predominantly of the left
hemisphere with particular involvement of more posterior cortical
areas (including posterior superior temporal/inferior parietal areas
and precuneus) that chieﬂy discriminates this syndrome anatomically
from other subtypes of PPA. The white matter VBM analysis here
reveals that this proﬁle of cortical damage is underpinned by
involvement chieﬂy of long association tracts in the left hemisphere.
Although there is overlap between the LPA subgroup with AD
pathology and the subgroup with GRN mutations, there are distinct
patterns of atrophy with more posterior temporo-parietal junction
and frontal lobe involvement in AD-PPA and more anterior temporal
lobe involvement in GRN-PPA. These neuroanatomical ﬁndings are
consistent with differences in the neuropsychological proﬁles of these
two groups. Cortical atrophy in the AD-PPA group here appears more
extensive than previously reported in LPA (Gorno-Tempini et al.,
2004, 2008): this may have been a correlate of relatively more severe
disease in our AD-PPA group. This severity issue might also account
for the more extensive intrahemispheric atrophy of the LPA cases in
relation to the SD and PNFA cases here. However, interpretation of
severity effects is problematic where severity measures are closely
correlated with the speciﬁc effects of the disease process: clues that
severity is not the entire explanation for the extensive left
hemispheric damage in our LPA group are the somewhat shorter
mean disease duration for the combined LPA group (Table 1) and the
striking asymmetry of both anatomical damage and neuropsycholog-
ical functions (e.g. normal object perception: Table 1) in the GRN-PPAsubgroup, suggesting that the disease process in these cases
preferentially affects a distributed left hemisphere network.
Our ﬁndings in the SD and PNFA groups corroborate the work of
previous studies, and provide further information about the integrity
of white matter pathways that are likely to be critical in binding
cortical areas into distributed networks that mediate particular
language functions (Scott et al., 2003; Spitsyna et al., 2006; Awad et
al., 2007; Seeley et al., 2009). In SD there was asymmetrical, left
greater than right anterior temporal lobe atrophy with less marked
involvement of orbitofrontal cortex (Galton et al., 2001; Rosen et al.,
2002; Rohrer et al., 2009). Of note, all of the SD cases here had left
temporal lobe onset (no cases with right temporal lobe onset were
ascertained during the period of the study). In PNFA there was left
inferior frontal lobe, insula and superior temporal lobe atrophy with
less marked involvement of the caudate and anterior parietal lobe
(Nestor et al., 2003; Gorno-Tempini et al., 2004; Ogar et al., 2007;
Rohrer et al., 2009). White matter disease has been little studied in SD
and PNFA, however one diffusion tensor imaging study in a mixed
“temporal variant” FTLD cohort (Borroni et al., 2007) showed
involvement of white matter tracts, including inferior longitudinal
fasciculus, inferior fronto-occipital fasciculus, callosal and superior
longitudinal fasciculus. The present study with stratiﬁcation of PPA
subgroups is consistent both with previous neuroanatomical ﬁndings
and with the distinctive neuropsychological proﬁles of SD and PNFA.
In SD, there was predominant involvement of anterior temporal
cortices and white matter tracts (fornix, inferior longitudinal
fasciculus and uncinate fasciculus) implicated in semantic processing
(Spitsyna et al., 2006); while in PNFA, there was predominant
involvement of inferior frontal, insular and parieto-temporal cortices
Fig. 5. VBM analysis on white matter regions in PPA subgroups relative to healthy controls and (bottom row) in the GRN-PPA subgroup relative to other disease groups. For each axial
section, the left hemisphere is shown on the left; sagittal sections are through the left hemisphere. For control comparisons, maps are thresholded at pb0.05 after FDR correction
over the whole brain volume; for disease group comparisons, maps are thresholded at pb0.001 uncorrected. White matter differences are color coded (red-yellow) in terms of
t-score as indicated on the color bar (right).The AD-PPA subgroup showed no signiﬁcant areas of white matter loss relative to other disease groups at the prescribed threshold.
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fasciculus) implicated in speech production (Scott et al., 2003).
The LPA syndrome is deﬁned by the presence of a primary language
disorder with the key constellation of impoverished though non-
effortful spontaneous speech marred by prominent word-ﬁnding
pauses and less prominent phonemic errors, anomia, impaired
sentence comprehension and impaired repetition particularly of
sentences (Gorno-Tempini et al., 2004, 2008). This language disorder
is associatedwith reduced digit span (indicative of a phonological store
deﬁcit). Neuropsychological assessment of the present cases corrobo-
rated these features and demonstrated additional dominant parietal
lobe deﬁcits (dyscalculia, deep/phonological dyslexia or limb apraxia,
alone or in combination). Although a primary defect of phonological
working memory has been proposed in LPA (Gorno-Tempini et al.,
2008), it is unlikely that the primary cognitive defect in this
degenerative syndrome is restricted to a single information processing
module. For example, anomia and word-ﬁnding pauses might reﬂect a
primary word retrieval deﬁcit or a more speciﬁc phonological access
deﬁcit linked to disruption of inferior parietal or posterior superior
temporal lobe areas, while limb apraxia is likely to reﬂect involvement
of a distinct network mediating the control of voluntary action that
includes the left parietal lobe. The pattern of deﬁcits in LPA suggests
involvement of the left parieto-temporal junction and retrosplenial
region and functional connections in the dorsal language processing
stream linking to inferior frontal areas (Rohrer et al., 2008a; Awad et al.,
2007; Wong et al., 2009). This pattern is likely to be relatively speciﬁc
for LPA: a similar pattern has emerged in previous neuroanatomical
studies of the syndrome (Gorno-Tempini et al., 2004, 2008), andfurthermore, direct comparison with SD and PNFA cases here revealed
distinct group-speciﬁc patterns of atrophy involving both cortex and
whitematter tracts.Wepropose that LPA is a network-based syndrome
that implicates distributed dominant hemisphere cortices and white
matter connections previously shown to be critical for the production
and analysis of language in normal functional imaging (Awad et al.,
2007) and focal lesion (Hillis, 2007) studies.
Theﬁnding that themajority of the LPA cases hadCSF biomarkers in
keeping with AD pathology is consistent with a previous study in
which64% (7/11 cases) of patientswith LPAhadADpathology:most of
the other cases had FTLD-U pathology, though further genetic analysis
was not undertaken (Mesulam et al., 2008). If LPA signals an atypical
language presentation of AD in a high proportion of cases, it is
noteworthy that the patternof anatomical changeswehavedelineated
here could be interpreted as a highly asymmetrical variant of the
anatomical proﬁle described in typical amnestic AD, with involvement
of themedial temporal lobe, temporo-parietal junction and precuneus
(Scahill et al., 2002). Indeed, language dysfunction and parietal signs
frequently develop in the course of typical amnestic AD (Croot et al.,
2000; Harasty et al., 2001; Taler et al., 2008) and an atypical language
variant of AD has been described, of which many cases appear to have
had an LPA syndrome (Galton et al., 2000; Alladi et al., 2007).
In this study, 22% of patients diagnosed with LPA (2/9) were found
to have GRN mutations, which have been shown previously to be
associatedwith asymmetrical hemispheric cortical atrophy frequently
involving the parietal lobe (Beck et al., 2008; Rohrer et al., 2008b; Le
Ber et al., 2008). The GRN-PPA group ﬁtted most closely the LPA
subtype of PPA rather than the other two subtypes (and were so
992 J.D. Rohrer et al. / NeuroImage 49 (2010) 984–993classiﬁed prior to discovery of their mutation), and it is noteworthy
that no GRN mutations were discovered in patients representing
other PPA syndromes in this series. However, detailed subgroup
analysis of neuroimaging and neuropsychological data suggests that
despite the overlap there are certain features which may help to
distinguish LPA in association with GRN mutations from LPA likely to
be caused by AD pathology. On neuropsychological assessment, our
GRN-PPA patients had more severe deﬁcits of naming, single word
comprehension, and vocabulary-based (irregular word) reading.
Anatomically (in common with SD), this argues for involvement of
dominant anterior temporal lobe mechanisms in GRN-PPA, and
indeed, the neuroimaging signature of GRN-PPA here was strikingly
asymmetric, with more severe anterior temporal lobe involvement
(and more severe white matter involvement) than with AD-PPA. This
neuroanatomical correlate implicates the ventral language processing
pathway linking the posterior superior temporal lobe with more
anterior temporal areas in the dominant hemisphere (Spitsyna et al.,
2006), suggesting that the GRN-associated subtype of LPA may be a
dual-pathway disease. Caution is clearly required in interpreting these
ﬁndings, due both to the small number of patients studied and the
current lack of pathological conﬁrmation in the non-GRN LPA group:
further work is needed to characterize the GRN-PPA syndrome fully
and to establish its true relation to non-GRN LPA, as well as PNFA and
SD. We regard the present data as important preliminary evidence
which will require substantiation in future studies with larger cohorts
and histopathological correlation.
In summary, LPA has a neuroanatomical proﬁle that is consistent
with the clinical and neuropsychological features of this syndrome.
The LPA proﬁle overlaps with other PPA syndromes, but is
distinguished chieﬂy by more extensive involvement of posterior
elements of the language network. AD pathology is likely to account
for most cases of LPA, with a signiﬁcant minority of other molecular
pathologies, notably GRN mutations, causing a similar syndrome. As
with any disorder producing aphasia, LPA provides information
about the organization of language networks that is complementary
to functional imaging studies in healthy subjects, by delineating
areas that are critical for (rather than simply associated with)
particular functions. However, the speciﬁc neurobiological impor-
tance of our ﬁndings is threefold. Firstly, the LPA syndrome as a
clinico-anatomical entity has a proﬁle of brain damage that is
complementary to the previously described “network-based” dis-
orders of SD and PNFA. Secondly, LPA suggests a mechanism by
which involvement of dominant temporo-parietal junctional areas
produces a core deﬁcit affecting manipulation of phonological
information with spread of disease through anatomically and
functionally connected language pathways: this predicts a pattern
of disease evolution in LPA which could be tested empirically in
longitudinal studies. Finally, the association of a similar syndrome
with GRN mutations provides a speciﬁc molecular substrate for
language network dysfunction. Viewed from this perspective, LPA
represents a unique “experiment of nature” that illustrates the
effects of progressive erosion of the distributed human language
network. Further behavioral and pathophysiological studies includ-
ing detailed cross-sectional and longitudinal correlation of neuro-
linguistic functions with anatomical substrates are needed to deﬁne
the core components of the LPA syndrome and their brain basis,
which may lie ultimately with disordered connectivity in distributed
dominant hemispheric networks.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.neuroimage.2009.08.002.
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